Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Academy Of Military Medical Sciences has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, so each current assignment is spread across a separate examiner and technical-unit context.
YAMASAKI, ROBERT J is the busiest examiner, with 1 pending matter. Counsel should maintain distinct prosecution histories and avoid relying on a common examiner approach across the docket. Portfolio review can still identify recurring scientific or claim issues, but responses should be tailored to the individual art-unit record.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YAMASAKI, ROBERT J | 1 | 67.4% | +44.1% |
| HERNANDEZ, JACKSON J | 1 | 50.7% | +39.2% |
| EDWARDS, LYDIA E | 1 | 60.1% | +6.0% |
| LEE, WILLIAM Y | 1 | 48.0% | +34.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730739 | METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR | YAMASAKI, ROBERT J | — |
| 18017710 | APPLICATION OF CANNABIDIOL IN TREATMENT OF CORONAVIRUS INFECTIONS | HERNANDEZ, JACKSON J | — |
| 17378415 | USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION | LEE, WILLIAM Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730739 | METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR | YAMASAKI, ROBERT J | — |
| 18017710 | APPLICATION OF CANNABIDIOL IN TREATMENT OF CORONAVIRUS INFECTIONS | HERNANDEZ, JACKSON J | — |
| 17378415 | USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| 1627 | 1 |
| 1796 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18730739 | METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR | YAMASAKI, ROBERT J | 1657 | §103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18017710 | APPLICATION OF CANNABIDIOL IN TREATMENT OF CORONAVIRUS INFECTIONS | HERNANDEZ, JACKSON J | 1627 | §103§112 | Non-Final OA | — | Pending | Jan 24, 2023 |
| 17627747 | SYSTEM AND METHOD FOR PREPARING MRNA | EDWARDS, LYDIA E | 1796 | §112 | Final Rejection | 5d overdue | Pending | Jan 17, 2022 |
| 17378415 | USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION | LEE, WILLIAM Y | 1623 | §103§112 | Non-Final OA | — | Pending | Jul 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAcademy Of Military Medical Sciences has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Robert J Yamasaki has the most, with 1 of Academy Of Military Medical Sciences's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
